Sequoia Capital

Sequoia Capital is a prominent venture capital firm founded in 1972 and based in Menlo Park, California. The firm specializes in investing across various stages of startups, including seed, early, and growth stages, and focuses on sectors such as technology, healthcare, financial services, internet, and mobile. Sequoia typically invests between $100,000 and $1 million in seed companies, $1 million to $10 million in early-stage ventures, and $10 million to $100 million in growth investments. The firm operates globally, with significant activities in regions like Israel, China, and India, where it partners with dynamic founders to build successful companies. Sequoia's extensive portfolio includes notable firms and offers valuable insights and resources, benefiting from decades of experience in the venture capital landscape.

Gian Adhitya

Associate

Rohit Agarwal

Investment Analyst

Akshay Agarwal

Associate

Suraj Agarwalla

Associate

Ashish Agrawal

Managing Director

Abheek Anand

Managing Director

Rajan Anandan

Managing Director

Bogomil Balkansky

Partner

Julien Bek

Partner

Mohit Bhatnagar

Managing Director

Roelof Botha

Executive

Jaime Bott

Partner of Human Capital

Anni Cai

Associate

Sakshi Chopra

Principal

William Coughran Ph.D

Partner

Chinmaya Golecha

VP

Ajey Gore

Operating Partner of Technology

Pat Grady

Partner

Irwin R. Gross

MD

Rachit Gupta

Associate

Kriti Gupta

Associate

Augustus Ilag

Associate

SK Jain

Co-Founderand MD

Amit Jain

Managing Director

Steve Yue Ji

Partner

Liu Jiang

Partner

Sandeep Kapoor

CLO and Compliance Officer, India

Aakash Kapoor

VP

Pieter Kemps

Principal

Kais Khimji

Partner

Shailesh Lakhani

Principal

Jess Lee

Partner

Doug Leone

Partner

Alfred Lin

Partner

Junrui Lin

Partner and Co-Head

Luciana Lixandru

Partner

Cherry Lu

Partner

Patricia Ma

Director of People Operations

Shaun Maguire Ph.D

Partner

Nipun Mehra

VP and Investment Advisor

Matthew Miller

Partner, Growth

Ishaan Mittal

Principal

Abhishek Mohan

Vice President

Anirudh Bose Mullick

Head of Recruitment and VP

Shreyas Nair

Senior Associate

Kevin Pan

Managing Director

Prachi Pawar

Associate

Mayank Porwal

VP

Enita Pu

Partner

Amrut Rajkarne

Associate

GV Ravishankar

Managing Director

Andrew Reed

Partner

Prasanna Rengarajan

Associate

Anandamoy Roychowdhary

Principal

Anjana Sasidharan

Principal

Harshjit Sethi

Principal

Tejeshwi Sharma

Managing Director

Navendu Sharma

Associate

Neil Shen

Managing Partner

Bharat Singh

Chief Financial Officer

Thomas Stephenson

Partner

Amy Sun

Partner

Johan Surani

vice_president

Ian Taylor

Head of scouts

Shraeyansh Thakur

Investment Analyst

Mike Vernal

Partner

Jeffrey Wang

Managing Partner & Portfolio Manager

Shenya Wang

Associate

Cen Wang

Partner, China

Klaus Wang

VP

Past deals in Nanotechnology

GenEdit

Series A in 2021
GenEdit, Inc. focuses on the development of novel, non-viral, nanoparticle-based delivery technology and enabling next generation CRISPR-based gene therapies. The foundation of our CRISPR-Nanoparticle Technology Platform is based on successfully engineering the individual components of the CRISPR system to overcome the limitations of existing delivery vehicles for CRISPR-based therapeutics.

Iambic Therapeutics

Series A in 2021
Iambic Therapeutics focuses on accelerating molecular discovery through its innovative quantum molecular simulation engine. By integrating artificial intelligence and automated synthetic development, the company aims to enhance the design of small-molecule therapeutics. This technology significantly improves the accuracy of molecular predictions, providing valuable insights for therapeutic discovery. Iambic Therapeutics is committed to transforming the drug development process, enabling physicians to access more precise molecular data and ultimately improving treatment outcomes.

Benchling

Series E in 2021
Benchling, Inc. is a developer of a cloud-based informatics platform tailored for life sciences research and development. The platform encompasses a range of integrated applications that enable scientists to design, share, and document experiments efficiently. Key offerings include an electronic lab notebook for experiment documentation, a biological registration system for managing inventory like plasmids and antibodies, and analytical tools for visualizing and collaborating on structured data. Benchling's software supports cutting-edge research techniques such as CRISPR and CAR-T immunotherapy, facilitating advancements in biotherapeutics, biofuels, and biomaterials. The company's solutions are utilized by researchers in biotech and pharmaceutical companies, as well as academic and government labs, streamlining workflows and enhancing collaboration across various research projects. Founded in 2012, Benchling is headquartered in San Francisco, California.

Carbon

Series E in 2019
Carbon, Inc. specializes in digital manufacturing solutions, focusing on the design, development, and production of advanced 3D printing technologies. The company's proprietary Digital Light Synthesis (DLS) technology incorporates digital light projection, oxygen-permeable optics, and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. Carbon's offerings include the SpeedCell system for streamlined production, additive manufacturing machines based on Continuous Liquid Interface Production (CLIP) technology, and automated Smart Part Washers. These innovations support various industries, including automotive, consumer products, dental, industrial, and life sciences, by enabling mass customization and on-demand inventory, while reducing waste and production time. Additionally, Carbon provides a range of polyurethane materials and consulting services to enhance manufacturing capabilities. Founded in 2013 by Dr. Joseph DeSimone and Philip DeSimone, Carbon is headquartered in Redwood City, California.

GenEdit

Seed Round in 2018
GenEdit, Inc. focuses on the development of novel, non-viral, nanoparticle-based delivery technology and enabling next generation CRISPR-based gene therapies. The foundation of our CRISPR-Nanoparticle Technology Platform is based on successfully engineering the individual components of the CRISPR system to overcome the limitations of existing delivery vehicles for CRISPR-based therapeutics.

Berkeley Lights

Series E in 2018
Berkeley Lights, Inc. is a digital cell biology company based in Emeryville, California, established in 2011. The company focuses on accelerating the development and commercialization of biotherapeutics and other cell-based products through its integrated platform. This platform includes proprietary consumables, such as OptoSelect chips and reagent kits, along with automation systems and workflow software. Utilizing micro-droplet technology, Berkeley Lights offers research and development services that transform how scientists study cell interactions, significantly enhancing the efficiency of cellular therapies. Their solutions cater to various sectors, including biotherapeutic discovery, cellular therapy manufacturing, synthetic biology, and agricultural biotechnology, helping clients meet the increasing demands of cell-based processes.

Carbon

Series D in 2017
Carbon, Inc. specializes in digital manufacturing solutions, focusing on the design, development, and production of advanced 3D printing technologies. The company's proprietary Digital Light Synthesis (DLS) technology incorporates digital light projection, oxygen-permeable optics, and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. Carbon's offerings include the SpeedCell system for streamlined production, additive manufacturing machines based on Continuous Liquid Interface Production (CLIP) technology, and automated Smart Part Washers. These innovations support various industries, including automotive, consumer products, dental, industrial, and life sciences, by enabling mass customization and on-demand inventory, while reducing waste and production time. Additionally, Carbon provides a range of polyurethane materials and consulting services to enhance manufacturing capabilities. Founded in 2013 by Dr. Joseph DeSimone and Philip DeSimone, Carbon is headquartered in Redwood City, California.

Carbon

Series C in 2016
Carbon, Inc. specializes in digital manufacturing solutions, focusing on the design, development, and production of advanced 3D printing technologies. The company's proprietary Digital Light Synthesis (DLS) technology incorporates digital light projection, oxygen-permeable optics, and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. Carbon's offerings include the SpeedCell system for streamlined production, additive manufacturing machines based on Continuous Liquid Interface Production (CLIP) technology, and automated Smart Part Washers. These innovations support various industries, including automotive, consumer products, dental, industrial, and life sciences, by enabling mass customization and on-demand inventory, while reducing waste and production time. Additionally, Carbon provides a range of polyurethane materials and consulting services to enhance manufacturing capabilities. Founded in 2013 by Dr. Joseph DeSimone and Philip DeSimone, Carbon is headquartered in Redwood City, California.

GenEdit

Pre Seed Round in 2016
GenEdit, Inc. focuses on the development of novel, non-viral, nanoparticle-based delivery technology and enabling next generation CRISPR-based gene therapies. The foundation of our CRISPR-Nanoparticle Technology Platform is based on successfully engineering the individual components of the CRISPR system to overcome the limitations of existing delivery vehicles for CRISPR-based therapeutics.

Berkeley Lights

Series C in 2015
Berkeley Lights, Inc. is a digital cell biology company based in Emeryville, California, established in 2011. The company focuses on accelerating the development and commercialization of biotherapeutics and other cell-based products through its integrated platform. This platform includes proprietary consumables, such as OptoSelect chips and reagent kits, along with automation systems and workflow software. Utilizing micro-droplet technology, Berkeley Lights offers research and development services that transform how scientists study cell interactions, significantly enhancing the efficiency of cellular therapies. Their solutions cater to various sectors, including biotherapeutic discovery, cellular therapy manufacturing, synthetic biology, and agricultural biotechnology, helping clients meet the increasing demands of cell-based processes.

Carbon

Series C in 2015
Carbon, Inc. specializes in digital manufacturing solutions, focusing on the design, development, and production of advanced 3D printing technologies. The company's proprietary Digital Light Synthesis (DLS) technology incorporates digital light projection, oxygen-permeable optics, and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. Carbon's offerings include the SpeedCell system for streamlined production, additive manufacturing machines based on Continuous Liquid Interface Production (CLIP) technology, and automated Smart Part Washers. These innovations support various industries, including automotive, consumer products, dental, industrial, and life sciences, by enabling mass customization and on-demand inventory, while reducing waste and production time. Additionally, Carbon provides a range of polyurethane materials and consulting services to enhance manufacturing capabilities. Founded in 2013 by Dr. Joseph DeSimone and Philip DeSimone, Carbon is headquartered in Redwood City, California.

Carbon

Series B in 2015
Carbon, Inc. specializes in digital manufacturing solutions, focusing on the design, development, and production of advanced 3D printing technologies. The company's proprietary Digital Light Synthesis (DLS) technology incorporates digital light projection, oxygen-permeable optics, and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. Carbon's offerings include the SpeedCell system for streamlined production, additive manufacturing machines based on Continuous Liquid Interface Production (CLIP) technology, and automated Smart Part Washers. These innovations support various industries, including automotive, consumer products, dental, industrial, and life sciences, by enabling mass customization and on-demand inventory, while reducing waste and production time. Additionally, Carbon provides a range of polyurethane materials and consulting services to enhance manufacturing capabilities. Founded in 2013 by Dr. Joseph DeSimone and Philip DeSimone, Carbon is headquartered in Redwood City, California.

Carbon

Series A in 2013
Carbon, Inc. specializes in digital manufacturing solutions, focusing on the design, development, and production of advanced 3D printing technologies. The company's proprietary Digital Light Synthesis (DLS) technology incorporates digital light projection, oxygen-permeable optics, and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. Carbon's offerings include the SpeedCell system for streamlined production, additive manufacturing machines based on Continuous Liquid Interface Production (CLIP) technology, and automated Smart Part Washers. These innovations support various industries, including automotive, consumer products, dental, industrial, and life sciences, by enabling mass customization and on-demand inventory, while reducing waste and production time. Additionally, Carbon provides a range of polyurethane materials and consulting services to enhance manufacturing capabilities. Founded in 2013 by Dr. Joseph DeSimone and Philip DeSimone, Carbon is headquartered in Redwood City, California.
Koncen BioScience was founded by a group of Chinese who returned to the country after completing their educations overseas. This high-technology biomedical enterprise offers integrated research and development, along with manufacturing and marketing services, all focused on blood purification technologies and products.

A123 Systems

Series D in 2007
A123 Systems is a prominent developer and manufacturer of advanced lithium-ion batteries and energy storage systems. The company leverages innovative nanoscale materials initially developed at MIT to create its proprietary Nanophosphate electrode technology, which offers significant advantages over competing high-power technologies. A123's battery cells and electrode designs are engineered to reduce costs per watt and per watt-hour, while also providing higher voltage compared to other long-life battery systems. This results in lower overall pack costs and enhanced price-performance due to the batteries' long lifespan, which minimizes lifecycle costs. A123 Systems serves clients across various industries by delivering efficient power solutions that increase battery life and safety in electronic devices. Competitors in the space include Valence, Saft, and Lion Cells.

A123 Systems

Series C in 2007
A123 Systems is a prominent developer and manufacturer of advanced lithium-ion batteries and energy storage systems. The company leverages innovative nanoscale materials initially developed at MIT to create its proprietary Nanophosphate electrode technology, which offers significant advantages over competing high-power technologies. A123's battery cells and electrode designs are engineered to reduce costs per watt and per watt-hour, while also providing higher voltage compared to other long-life battery systems. This results in lower overall pack costs and enhanced price-performance due to the batteries' long lifespan, which minimizes lifecycle costs. A123 Systems serves clients across various industries by delivering efficient power solutions that increase battery life and safety in electronic devices. Competitors in the space include Valence, Saft, and Lion Cells.

A123 Systems

Series B in 2006
A123 Systems is a prominent developer and manufacturer of advanced lithium-ion batteries and energy storage systems. The company leverages innovative nanoscale materials initially developed at MIT to create its proprietary Nanophosphate electrode technology, which offers significant advantages over competing high-power technologies. A123's battery cells and electrode designs are engineered to reduce costs per watt and per watt-hour, while also providing higher voltage compared to other long-life battery systems. This results in lower overall pack costs and enhanced price-performance due to the batteries' long lifespan, which minimizes lifecycle costs. A123 Systems serves clients across various industries by delivering efficient power solutions that increase battery life and safety in electronic devices. Competitors in the space include Valence, Saft, and Lion Cells.